digital health companies glp-1 programs What's next for innovation: A primer on the race reshaping pharma and chronic disease care GLP-1 Toolkit

Mrinalika RoyandSriparna Roy

This guide explores prescription options, compounded alternatives, and how genetic and biomarker factors may inform provider conversations about suitability

$149$299/mo

Novo Nordisk has been handed a crucial legal win by China's Supreme Court, which has upheld the company's patent protection on GLP-1 agonist semaglutide used for diabetes and weight loss

With one capsule daily after a main meal, this formula provides two powerful and effective botanicals to help you feel full faster and stay full longer.*

Dipeptidyl peptidase 4 inhibitors are now widely used in the treatment of patients with type 2 diabetes mellitus